Specific binding to plasma membrane is the first step in the uptake of non-transferrin iron by cultured cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1369, Issue 1, 1998, Pages 103-108

  Musílková, Jana ^a   Kriegerbecková, Karin ^a   Krůšek, Jan ^b   Kovář, Jan ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

HeLa cell; Iron binding site; Iron uptake; Non transferrin iron transport

Indexed keywords

FERRIC CITRATE; IRON;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; HUMAN; HUMAN CELL; IRON METABOLISM; IRON TRANSPORT; PRIORITY JOURNAL;

BINDING SITES; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CLONE CELLS; HELA CELLS; HUMANS; IRON; TRANSFERRIN;

EID: 0032472787     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(97)00214-9     Document Type: Article

References (25)

1. [1] A. Dautry-Varsat, A. Ciechanover, H.F. Lodish, Proc. Natl. Acad. Sci. USA 80 (1983) 2258-2262.
2. [2] R.D. Klausner, G. Ashwell, J. van Renswoude, J.B. Harford, K.R. Bridges, Proc. Natl. Acad. Sci. USA 80 (1983) 2262-2266.
3. [3] P. Brissot, T.L. Wright, W.-L. Ma, R.A. Weisiger, J. Clin. Invest. 76 (1985) 1463-1470.
4. [4] T.L. Wright, P. Brissot, W.-L. Ma, R.A. Weisiger, J. Biol. Chem. 261 (1986) 10909-10914.
5. [5] M.E. Conrad, J.N. Umbreit, R.D.A. Peterson, E.G. Moore, K.P. Harper, Blood 81 (1993) 517-521.
6. [6] C.M. Craven, J. Alexander, M. Eldridge, J.P. Kushner, S. Bernstein. J. Kaplan, Proc. Natl. Acad. Sci. USA. 84 (1987) 3457-3461.
7. [7] P. Basset, Y. Quesneau, J. Zwiller, Cancer Res. 46 (1986) 1644-1647.
8. [8] D. Richardson, E. Baker, Biochim. Biophys. Acta 1093 (1991) 20-28.
9. [9] R. Teichmann, W. Stremmel, J. Clin. Invest. 86 (1990) 2145-2153.
10. [10] J. Kaplan, I. Jordan, A. Sturrock, J. Biol. Chem. 266 (1991) 2997-3004.
11. [11] R.S. Inman, M. Wessling-Resnick, J. Biol. Chem. 268 (1993) 8521-8528.
12. [12] Z.M. Qian, E.H. Morgan, Biochim. Biophys. Acta 1073 (1991) 456-462.
13. [13] P.A. Seligman, J. Kovar, R.B. Schleicher, E.W. Gelfand, Blood 78 (1991) 1526-1531.
14. [14] A. Sturrock, J. Alexander, J. Lamb, C.M. Craven, J. Kaplan, J. Biol. Chem. 265 (1990) 3139-3145.
15. [15] K. Kriegerbecková, L. Döpper, B. Scheiber, J. Kovář, H. Goldenberg, Eur. J. Clin. Chem. Clin. Biochem. 33 (1995) 791-797.
16. [16] B. Sarkar, Canad. J. Biochem. 48 (1970) 1339-1350.
17. [17] E.H. Morgan, Molec. Aspects Med. 4 (1981) 1-123.
18. [18] J. Kovář, F. Franěk, Biotechnol. Lett. 9 (1987) 259-264.
19. [19] J. Kovář, F. Franěk, Exp. Cell. Res. 182 (1989) 358-369.
20. [20] V. Neumanova, D.R. Richardson, K. Kriegerbeckova, J. Kovar, In Vitro Cell. Dev. Biol. 31 (1995) 625-632.
21. [21] J.P. Bennett, in: H.I. Yamamura, S.J. Emma, M. Kubar (Eds.), Neurotransmitter Receptor Binding, Raven Press, New York, 1978, pp. 57-90
22. [22] A.V. Hill, J. Physiol. 40 (1910) 4-6.
23. [23] S. Kotrlý, L. Šůcha, in: R.A. Chalmers, M. Masson (Eds.), Handbook of Chemical Equilibria in Analytical Chemistry, Ellis Horwood series in Analytical Chemistry, Ellis Horwood Limited, Chichester, 1985.
24. [24] E.N. Baker, H.M. Baker, C.A. Smith, M. Stebbins, M. Kahn, K.E. Hellström, I. Hellström, FEBS Lett. 298 (1992) 215-218.
25. [25] M.L. Kennard, D.R. Richardson, R. Gabathuler, P. Ponka, W.A. Jefferies, EMBO J. 14 (1995) 4178-4186.